vs
Orthofix Medical Inc.（OFIX）与Wingstop Inc.（WING）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是Wingstop Inc.的1.2倍（$219.9M vs $183.7M），Wingstop Inc.净利率更高（16.3% vs -1.0%，领先17.3%），Wingstop Inc.同比增速更快（7.4% vs 2.0%），过去两年Wingstop Inc.的营收复合增速更高（8.6% vs 8.0%）
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
Wingstop Inc.是美国知名跨国快餐连锁品牌，核心产品为布法罗鸡翅，旗下门店均采用20世纪30至40年代喷气时代前的航空主题装饰风格，目前业务已覆盖全球多个国家和地区。
OFIX vs WING — 直观对比
营收规模更大
OFIX
是对方的1.2倍
$183.7M
营收增速更快
WING
高出5.4%
2.0%
净利率更高
WING
高出17.3%
-1.0%
两年增速更快
WING
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $219.9M | $183.7M |
| 净利润 | $-2.2M | $29.9M |
| 毛利率 | 71.1% | 86.5% |
| 营业利润率 | 0.2% | 27.4% |
| 净利率 | -1.0% | 16.3% |
| 营收同比 | 2.0% | 7.4% |
| 净利润同比 | 92.4% | — |
| 每股收益（稀释后） | $-0.05 | $1.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OFIXWING
| Q1 26 | — | $183.7M | ||
| Q4 25 | $219.9M | $175.7M | ||
| Q3 25 | $205.6M | $175.7M | ||
| Q2 25 | $203.1M | $174.3M | ||
| Q1 25 | $193.6M | $171.1M | ||
| Q4 24 | $215.7M | $161.8M | ||
| Q3 24 | $196.6M | $162.5M | ||
| Q2 24 | $198.6M | $155.7M |
净利润OFIXWING
| Q1 26 | — | $29.9M | ||
| Q4 25 | $-2.2M | $26.8M | ||
| Q3 25 | $-22.8M | $28.5M | ||
| Q2 25 | $-14.1M | $26.8M | ||
| Q1 25 | $-53.1M | $92.3M | ||
| Q4 24 | $-29.1M | $26.8M | ||
| Q3 24 | $-27.4M | $25.7M | ||
| Q2 24 | $-33.4M | $27.5M |
毛利率OFIXWING
| Q1 26 | — | 86.5% | ||
| Q4 25 | 71.1% | — | ||
| Q3 25 | 72.2% | — | ||
| Q2 25 | 68.7% | — | ||
| Q1 25 | 62.8% | — | ||
| Q4 24 | 69.0% | 85.6% | ||
| Q3 24 | 68.7% | 85.0% | ||
| Q2 24 | 67.8% | 85.4% |
营业利润率OFIXWING
| Q1 26 | — | 27.4% | ||
| Q4 25 | 0.2% | 26.7% | ||
| Q3 25 | -8.3% | 27.9% | ||
| Q2 25 | -7.9% | 25.9% | ||
| Q1 25 | -25.2% | 22.4% | ||
| Q4 24 | -5.3% | 25.9% | ||
| Q3 24 | -9.6% | 24.5% | ||
| Q2 24 | -12.5% | 26.5% |
净利率OFIXWING
| Q1 26 | — | 16.3% | ||
| Q4 25 | -1.0% | 15.2% | ||
| Q3 25 | -11.1% | 16.2% | ||
| Q2 25 | -6.9% | 15.4% | ||
| Q1 25 | -27.4% | 53.9% | ||
| Q4 24 | -13.5% | 16.5% | ||
| Q3 24 | -13.9% | 15.8% | ||
| Q2 24 | -16.8% | 17.7% |
每股收益（稀释后）OFIXWING
| Q1 26 | — | $1.08 | ||
| Q4 25 | $-0.05 | $0.99 | ||
| Q3 25 | $-0.57 | $1.02 | ||
| Q2 25 | $-0.36 | $0.96 | ||
| Q1 25 | $-1.35 | $3.24 | ||
| Q4 24 | $-0.76 | $0.91 | ||
| Q3 24 | $-0.71 | $0.88 | ||
| Q2 24 | $-0.88 | $0.93 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $82.0M | $128.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $450.0M | — |
| 总资产 | $850.6M | $648.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资OFIXWING
| Q1 26 | — | $128.8M | ||
| Q4 25 | $82.0M | $196.6M | ||
| Q3 25 | $62.9M | $237.6M | ||
| Q2 25 | $65.6M | $227.9M | ||
| Q1 25 | $58.0M | $251.4M | ||
| Q4 24 | $83.2M | $315.9M | ||
| Q3 24 | $30.1M | $84.0M | ||
| Q2 24 | $26.4M | $96.7M |
总债务OFIXWING
| Q1 26 | — | — | ||
| Q4 25 | — | $1.2B | ||
| Q3 25 | $157.2M | — | ||
| Q2 25 | $157.0M | — | ||
| Q1 25 | $156.9M | — | ||
| Q4 24 | $157.0M | $1.2B | ||
| Q3 24 | $118.5M | — | ||
| Q2 24 | $118.0M | — |
股东权益OFIXWING
| Q1 26 | — | — | ||
| Q4 25 | $450.0M | $-736.8M | ||
| Q3 25 | $442.5M | $-702.6M | ||
| Q2 25 | $458.3M | $-686.0M | ||
| Q1 25 | $458.3M | $-715.0M | ||
| Q4 24 | $503.1M | $-675.6M | ||
| Q3 24 | $525.9M | $-447.5M | ||
| Q2 24 | $546.0M | $-437.5M |
总资产OFIXWING
| Q1 26 | — | $648.9M | ||
| Q4 25 | $850.6M | $693.4M | ||
| Q3 25 | $832.6M | $721.0M | ||
| Q2 25 | $837.2M | $708.3M | ||
| Q1 25 | $823.1M | $696.8M | ||
| Q4 24 | $893.3M | $716.2M | ||
| Q3 24 | $867.9M | $484.8M | ||
| Q2 24 | $882.0M | $451.8M |
负债/权益比OFIXWING
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 0.36× | — | ||
| Q2 25 | 0.34× | — | ||
| Q1 25 | 0.34× | — | ||
| Q4 24 | 0.31× | — | ||
| Q3 24 | 0.23× | — | ||
| Q2 24 | 0.22× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.7M | — |
| 自由现金流经营现金流 - 资本支出 | $16.8M | — |
| 自由现金流率自由现金流/营收 | 7.6% | — |
| 资本支出强度资本支出/营收 | 4.9% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-1.3M | — |
8季度趋势，按日历期对齐
经营现金流OFIXWING
| Q1 26 | — | — | ||
| Q4 25 | $27.7M | $57.3M | ||
| Q3 25 | $12.4M | $63.9M | ||
| Q2 25 | $11.6M | $6.6M | ||
| Q1 25 | $-18.4M | $25.3M | ||
| Q4 24 | $23.7M | $7.7M | ||
| Q3 24 | $11.7M | $69.0M | ||
| Q2 24 | $9.0M | $36.2M |
自由现金流OFIXWING
| Q1 26 | — | — | ||
| Q4 25 | $16.8M | $34.5M | ||
| Q3 25 | $2.5M | $61.7M | ||
| Q2 25 | $4.5M | $-7.8M | ||
| Q1 25 | $-25.1M | $17.3M | ||
| Q4 24 | $15.2M | $-8.6M | ||
| Q3 24 | $6.3M | $54.9M | ||
| Q2 24 | $-360.0K | $25.9M |
自由现金流率OFIXWING
| Q1 26 | — | — | ||
| Q4 25 | 7.6% | 19.6% | ||
| Q3 25 | 1.2% | 35.1% | ||
| Q2 25 | 2.2% | -4.5% | ||
| Q1 25 | -13.0% | 10.1% | ||
| Q4 24 | 7.0% | -5.3% | ||
| Q3 24 | 3.2% | 33.8% | ||
| Q2 24 | -0.2% | 16.6% |
资本支出强度OFIXWING
| Q1 26 | — | — | ||
| Q4 25 | 4.9% | 13.0% | ||
| Q3 25 | 4.8% | 1.3% | ||
| Q2 25 | 3.5% | 8.2% | ||
| Q1 25 | 3.5% | 4.7% | ||
| Q4 24 | 4.0% | 10.1% | ||
| Q3 24 | 2.7% | 8.7% | ||
| Q2 24 | 4.7% | 6.6% |
现金转化率OFIXWING
| Q1 26 | — | — | ||
| Q4 25 | — | 2.14× | ||
| Q3 25 | — | 2.24× | ||
| Q2 25 | — | 0.25× | ||
| Q1 25 | — | 0.27× | ||
| Q4 24 | — | 0.29× | ||
| Q3 24 | — | 2.68× | ||
| Q2 24 | — | 1.32× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
WING
| Royalty revenue, franchise fees and other | $87.5M | 48% |
| Advertising fees | $63.3M | 34% |
| Company-owned restaurant sales | $33.0M | 18% |
